3:00 PM
Aug 09, 2018
 |  BC Extra  |  Politics & Policy

China releases list of overseas drugs eligible for Priority Review

China’s Drug Evaluation Center posted a list of 48 drugs already approved in the U.S., EU or Japan that could be eligible for Priority Review in China.

Last December, China's State Drug Administration released guidance to implement a priority review pathway to accelerate the development and approval of new drugs with "significant clinical value" (see "CFDA Outlines Priority Review Pathway").

To speed up approval of these "urgently needed"...

Read the full 321 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >